Skip to content

We are conducting a 'medication effectiveness comparison study'. You may be assigned to either the norepinephrine group or the phenylephrine group. During the study, neither you nor your doctors will know which medication is being administered, ensuring objective evaluation of treatment effects.

Impact of Intraoperative Norepinephrine versus Phenylephrine Infusion on Postoperative Delirium in Geriatric Hip Fracture Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110434
Enrollment
Unknown
Registered
2025-10-14
Start date
2025-10-14
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive dysfunction following hip fracture surgery

Interventions

Group P:Phenylephrine was used during operation
Group N:Norepinephrine was used during operation

Sponsors

Lu'an Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion Criteria Elderly patients scheduled for elective hip fracture surgery who voluntarily participate in this trial after providing written informed consent (from both the patient and their legal guardian); 2.Age >= 65 years; 3.American Society of Anesthesiologists (ASA) physical status classification I-III; 4.No severe visual/auditory impairments that would hinder normal communication; 5.Preoperative use of the Montreal Cognitive Assessment Basic (MoCA-B) to ensure the absence of cognitive impairment and the ability to complete cognitive function tests prior to surgery.

Exclusion criteria

Exclusion criteria: 1.Exclusion Criteria Patient refusal or inability to cooperate with neuraxial anesthesia (e.g., spinal/epidural anesthesia). Poorly controlled hypertension preoperatively (SBP >= 180 mmHg or DBP >= 110 mmHg). Preoperative hypotension (SBP <90 mmHg or MAP <60 mmHg). Severe cardiac conditions, including: Significant arrhythmias Valvular stenosis Severe intracardiac shunting Impaired cardiac function Intraoperative acute cardiovascular events (e.g., severe hypotension, myocardial ischemia, or arrhythmia requiring intervention). Emergency surgery or concurrent participation in another clinical trial.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative delirium within 3 days;

Secondary

MeasureTime frame
Intraoperative hemodynamic data;Intraoperative regional cerebral oxygen saturation (rSO2) data;Postoperative VAS (Visual Analogue Scale) score;Renal function;Dosage of vasoactive drugs;Intraoperative adverse events;Arterial Blood Gas Analysis;Quality of Recovery-15 scale (QoR-15);Others;Baseline patient characteristics;Confusion Assessment Method-Revised;Postoperative adverse events;

Countries

China

Contacts

Public ContactMa Qigang

Lu'an Hospital of Traditional Chinese Medicine

maqigang@126.com+86 564 331 2464

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026